Company Filing History:
1 out of 1,001 
1 out of 1,866 
Years Active: 2019
Title: Joseph M Salamoun: Innovator in Cancer Treatment
Introduction
Joseph M Salamoun is a notable inventor based in Roanoke, VA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the inhibition of protein tyrosine phosphatase, which plays a crucial role in cancer progression.
Latest Patents
Joseph M Salamoun holds a patent for "Inhibitors of PTP4A3 for the treatment of cancer." This invention provides protein tyrosine phosphatase inhibitor compounds, along with their pharmaceutical compositions, uses, and methods of use in treating various cancers. The patent also discloses an improved synthesis of the protein tyrosine phosphatase inhibitor and precursor compound thienopyridone (5). He has 1 patent to his name.
Career Highlights
Throughout his career, Salamoun has worked with esteemed institutions such as the University of Virginia Patent Foundation and the University of Pittsburgh. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include John S Lazo and Elizabeth R Sharlow. Their collaborative efforts have further enhanced the impact of Salamoun's work in the field of cancer research.
Conclusion
Joseph M Salamoun is a dedicated inventor whose work in developing cancer treatment compounds has the potential to make a significant difference in the lives of many. His innovative approach and collaborations with leading institutions highlight his commitment to advancing medical science.